A Study to Evaluate the Safety of an Investigational Drug (Etoricoxib) in Patients With Osteoarthritis (OA) or Rheumatoid Arthritis (RA)(0663-066)
PHASE3CompletedINTERVENTIONAL
Enrollment
23,498
Participants
Timeline
Start Date
January 31, 2003
Primary Completion Date
May 31, 2006
Study Completion Date
May 31, 2006
Conditions
Rheumatoid Arthritis,Osteoarthritis
Interventions
DRUG
MK0663, etoricoxib
DRUG
Comparator: Diclofenac sodium
All Listed Sponsors
lead
Organon and Co
INDUSTRY
NCT00250445 - A Study to Evaluate the Safety of an Investigational Drug (Etoricoxib) in Patients With Osteoarthritis (OA) or Rheumatoid Arthritis (RA)(0663-066) | Biotech Hunter | Biotech Hunter